Mode
Text Size
Log in / Sign up

Nephrolithiasis

Part of Kidney Diseases

10 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Nephrolithiasis

18 trials tracked for Nephrolithiasis: 7 in phase 3 or 4 and 1 with published results. The most-cited published study has 128 citations.

18Trials tracked
7Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 4 Phase 3 3 Phase 2 3 Other / NA 8
  1. Phase 3 Hydrochlorothiazide for Kidney Stone Recurrence Prevention Completed · 128 cited
  2. Phase 4 A Randomized Trial of Preoperative Prophylactic Antibiotics Prior to Kidney Stone Surgery (Percutaneous Nephrolithotomy [PCNL]) Completed
  3. Phase 4 The Use of Belladonna and Opium Suppository in the Treatment of Postoperative Stent Pain Completed
  4. Phase 4 Narcotic-Free Percutaneous Nephrolithotomy Completed
  5. Phase 4 Vitamin D Repletion in Stone Formers With Hypercalciuria Completed
  6. Phase 3 Perioperative Pregabalin in Ureteroscopy: a Pilot Completed
Show 12 more trials
  1. Phase 3 Pain Outcomes of Non-opioid vs. Opioid Analgesia for Kidney Stone Surgery. Completed
  2. Phase 2 Effect of Antihistamines on Ureteral Stent-Related Symptoms Completed
  3. Phase 2 Use of Oral Probiotics to Reduce Urinary Oxalate Excretion Completed
  4. Phase 2 Evaluating ALLN-177 for Reducing Urinary Oxalate Excretion in Calcium Oxalate Kidney Stone Formers With Hyperoxaluria Completed
  5. N/A Noninvasive Electrical Stimulator as a Pain Control Treatment Post-ureteroscopy Completed
  6. N/A Trial Assessing Renal Damage During Ureteroscopy Completed
  7. N/A Intraoperative Cone-beam CT for Percutaneous Nephrolithotomy Completed
  8. N/A Evaluation of a Nonopioid Recovery Pathway Following Surgery for Kidney Stones Completed
  9. N/A A Pilot Study of Oxalate Absorption in Secondary Hyperoxaluria Completed
  10. N/A A Comparison of Ureteroscopic Treatment of Nephrolithiasis With and Without Moses Technology Completed
  11. N/A Thulium vs. Hol:YAG Laser Completed
  12. N/A Impact Ureteral Sheath Design During Ureteroscopy Completed

Showing the 18 most-cited and recently-updated of 18 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

What the trials found For clinicians

Nephrolithiasis: what the trials found

Management of nephrolithiasis includes various pharmacological and procedural interventions. Oxycodone (5mg) was evaluated for pain management, with associated Visual Analog Scale (VAS) scores recorded at 4.5, 5, 1, and 1 1. Ketorolac oral tablets were also studied; while no significant difference was found in satisfaction with pain relief or current pain intensity, a statistically significant difference was observed in peak pain intensity levels (p=0.006) 6.

Procedural interventions for the condition include the use of Thulium Fibre Laser [11, 15]. Other investigated treatments include Ergocalciferol 4, Pregabalin (300mg) 7, and nitrofurantoin monohydrate/macrocrystalline capsules, which were associated with varying grades of postoperative complications on the Clavien-Dindo scale 3.

Historical or alternative pharmacological combinations such as Belladonna and Opium were evaluated in relation to global quality of life scores on postoperative days 1 and 3 2.

Recent results — preliminary, needs further review

  • Fexofenadine Hcl (180mg) was studied for urinary symptoms and body pain, showing specific score changes in a Phase 2 trial 8.

For the clinician treating this condition

  • Ketorolac shows significant impact on peak pain intensity levels compared to control groups, though current pain intensity scores may not differ significantly 6.
  • Thulium Fibre Laser is an established procedural intervention for the management of nephrolithiasis [11, 15].
  • Pharmacological options range from opioids like Oxycodone 1 and Pregabalin 7 to non-opioid options such as Ketorolac 6 or nitrofurantoin 3.

AI synthesis of 7 cited trials, updated Jun 26, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Questions about Nephrolithiasis

What renal complications might occur in patients with inflammatory bowel disease?

Patients with inflammatory bowel disease face specific kidney risks including chronic kidney disease, glomerulonephritis, and nephrolithiasis, with some stones directly linked to medications like mesalazine.

Full answer →
Do people with inflammatory bowel disease have higher risks of kidney stones?

People with inflammatory bowel disease, especially Crohn's disease, have a higher risk of kidney stones due to malabsorption and chronic inflammation.

Full answer →